White coat hypertension

White coat hypertension
DiseasesDB	14138

WikiDoc Resources for White coat hypertension
Articles
Most recent articles on White coat hypertension Most cited articles on White coat hypertension Review articles on White coat hypertension Articles on White coat hypertension in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on White coat hypertension Images of White coat hypertension Photos of White coat hypertension Podcasts & MP3s on White coat hypertension Videos on White coat hypertension
Evidence Based Medicine
Cochrane Collaboration on White coat hypertension Bandolier on White coat hypertension TRIP on White coat hypertension
Clinical Trials
Ongoing Trials on White coat hypertension at Clinical Trials.gov Trial results on White coat hypertension Clinical Trials on White coat hypertension at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on White coat hypertension NICE Guidance on White coat hypertension NHS PRODIGY Guidance FDA on White coat hypertension CDC on White coat hypertension
Books
Books on White coat hypertension
News
White coat hypertension in the news Be alerted to news on White coat hypertension News trends on White coat hypertension
Commentary
Blogs on White coat hypertension
Definitions
Definitions of White coat hypertension
Patient Resources / Community
Patient resources on White coat hypertension Discussion groups on White coat hypertension Patient Handouts on White coat hypertension Directions to Hospitals Treating White coat hypertension Risk calculators and risk factors for White coat hypertension
Healthcare Provider Resources
Symptoms of White coat hypertension Causes & Risk Factors for White coat hypertension Diagnostic studies for White coat hypertension Treatment of White coat hypertension
Continuing Medical Education (CME)
CME Programs on White coat hypertension
International
White coat hypertension en Espanol White coat hypertension en Francais
Business
White coat hypertension in the Marketplace Patents on White coat hypertension
Experimental / Informatics
List of terms related to White coat hypertension

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

White coat hypertension, more commonly known as white coat syndrome, is a phenomenon in which patients exhibit elevated blood pressure in a clinical setting but not in other settings. It is believed that this is due to the anxiety some people experience during a clinic visit.

As the notion of "normal" is subjective and changes from individual to individual a reference measurement was necessary. As night-time and self measured values are often not subject to daily stress and clinical values are subject to unusual anxiety, daytime ambulatory blood pressure is used as a reference as it takes into account daily stress but not in excess. Due to specificity involved in diagnosis of white coat hypertension, many problems have been incurred in its diagnosis and treatment.

The term "masked hypertension" can be used to describe the contrasting phenomenon, where blood pressure is elevated during daily living, but not in an office setting.

Diagnosis

In studies, white coat hypertension can be defined as the presence of a defined hypertensive average blood pressure in an office setting but not at home.

Diagnosis is made difficult as a result of the unreliable measures taken from the conventional methods of detection. These methods often involve an interface with health care professionals and frequently results are tarnished by a list of factors including variability in the individual’s blood pressure, technical inaccuracies, anxiety of the patient, recent ingestion of pressor substances, and talking, amongst many other factors. The most common measure of blood pressure is taken from a noninvasive instrument called a sphygmomanometer. "A survey showed that 96% of primary care physicians habitually use a cuff size too small," adding to the difficulty in making an informed diagnosis. For such reasons, white coat hypertension cannot be diagnosed with a standard clinical visit. It can be reduced (but not eliminated) with automated blood pressure measurements over 15 to 20 minutes in a quiet part of the office or clinic.

Patients with white coat hypertension do not exhibit the signs indicative of trepidation and their increased blood pressure is often not accompanied by tachycardia. This is supported by studies that repeatedly indicate that 15%–30% of those thought to have mild hypertension as a result of clinic or office recordings display normal blood pressure and no unusual response to pressure stimulus. These persons did not show any specific characteristics such as age that may be indicative of a higher susceptibility to white coat hypertension.

Ambulatory blood pressure monitoring and patient self-measurement using a home blood pressure monitoring device is being increasingly used to differentiate those with white coat hypertension or experiencing the white coat effect from those with chronic hypertension. This does not mean that these methods are without fault. Daytime ambulatory values, despite taking into account stresses of everyday life when taken during the patient's daily routine, are still susceptible to the effects of daily variables such as physical activity, stress and duration of sleep. Ambulatory monitoring has been found to be the more practical and reliable method in detecting patients with white coat hypertension and for the prediction of target organ damage. Even as such, the diagnosis and treatment of white coat hypertension remains controversial.

Recent studies showed that home blood pressure monitoring is as accurate as a 24-hour ambulatory monitoring in determining blood pressure levels. Researchers at the University of Turku, Finland studied 98 patients with untreated hypertension. They compared patients using a home blood pressure device and those wearing a 24-hour ambulatory monitor. Researcher Dr. Niiranen said that "home blood pressure measurement can be used effectively for guiding anti-hypertensive treatment". Dr. Stergiou added that home tracking of blood pressure "is more convenient and also less costly than ambulatory monitoring."

Use of breathing patterns has been proposed as a technique for identifying white coat hypertension.

In one Turkish study of 438 consecutive patients, 38% were normotensive, 43% had white coat hypertension, 2% had masked hypertension, and 15% had sustained hypertension. Even patients taking medication for sustained hypertension who are normotensive at home may exhibit white coat hypertension in the office setting.

Implications for treatment

In general, individuals with white coat hypertension have lower morbidity than patients with sustained hypertension, but higher morbidity than the clinically normotensive.

However, it should be remembered that all the established published trials on the consequences of high blood pressure and the benefits of treating are based on one-time measurement in clinical settings rather than the generally slightly lower readings obtained from ambulatory recordings.

The debate and conflicting ideas revolve around whether or not it would be feasible to treat white coat hypertension, as there still is no conclusive evidence that a temporary rise in blood pressure during office visits has an adverse effect on health.

In fact, many cross sectional studies have shown that "target-organ damage (as exemplified by left ventricular hypertrophy) is less in white-coat hypertensive [patients] than in sustained hypertensive [patients] even after the allowance has been made for differences in clinic pressure". Many believe that patients with "white coat" hypertension do not require even very small doses of antihypertensive therapy as it may result in hypotension, but must still be careful as patients may show signs of vascular changes and may eventually develop hypertension.

See also

• Blood pressure
• Hypertension
• Home blood pressure monitoring

References

Faculty Of Medicine : White Coat Syndrome Template:Vascular diseases